PLXNA2 and chronic gastritis: The reported gastrointestinal adverse events may be caused by bile salt reabsorption (46), gut microbiota alteration (6), organic cation transporter (OCT) polymorphism (34, 47), OCT-1 inhibiting agents, age, female (48), chronic gastritis (49) and H.pylori infection (8).